Prostate cancer stem cells found to be moving target

Prostate cancer stem cells evolve into different cells as prostate cancer progresses becoming a moving target for therapy. Scientists must be prepared for the continual evolution of the stem cell as tumors adapt and become resistant to new and more potent therapies. With this knowledge, researchers can now design therapies that target the elements of the cancer stem cells that remain unchanged.